Oracle
ORCL
NVIDIA
NVDA
Microsoft
MSFT
D.R. Horton
DHI
Lennar Corp
LEN
US Stock MarketDetailed Quotes
CAMP Camp4 Therapeutics
- 5.800
- -0.740-11.31%
Close Jan 22 16:00 ET
- 5.690
- -0.110-1.90%
Post 20:01 ET
116.93MMarket Cap-2.20P/E (TTM)
6.490High5.010Low139.90KVolume6.490Open6.540Pre Close814.97KTurnover2.05%Turnover RatioLossP/E (Static)20.16MShares12.30052wk High-0.74P/B39.56MFloat Cap3.50052wk Low--Dividend TTM6.82MShs Float12.300Historical High--Div YieldTTM22.63%Amplitude3.500Historical Low5.825Avg Price1Lot Size
Camp4 Therapeutics News
Camp4 Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Michael P. Rubin(11.5%),Northpond Ventures II, LP(5.1%), etc.
Camp4 Therapeutics | SC 13D: Statement of acquisition of beneficial ownership by individuals-Amir Nashat(13.5%),Polaris Management Co. VII, L.L.C.(8.8%), etc.
Camp4 Therapeutics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-10% Owner Polaris Management Co. VII, L.L.C.
Camp4 Therapeutics | 3/A: Initial statement of beneficial ownership of securities (Amendment)-10% Owner Polaris Partners GP X, L.L.C.
Camp4 Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Marc Andreessen(10.9%),Benjamin Horowitz(10.9%), etc.
Camp4 Therapeutics | SC 13D: Statement of acquisition of beneficial ownership by individuals-Enavate Sciences GP, LLC(19.4%),Everest Aggregator, LP(19.4%)
Camp4 Therapeutics | SC 13D: Statement of acquisition of beneficial ownership by individuals-Andrew J. Schwab(15.0%),Dr. Kush Parmar(15.0%), etc.
Camp4 Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Northpond Ventures II GP, LLC
Camp4 Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner AH Equity Partners Bio I, L.L.C.
Camp4 Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Enavate Sciences GP, LLC
Camp4 Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Polaris Management Co. VII, L.L.C.
Camp4 Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner 5AM Partners VI, LLC
Camp4 Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Schwab Andrew J.
Camp4 Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Nashat Amir
Camp4 Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Holtzman Steven H
Camp4 Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Young Richard A
Camp4 Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Mandel-Brehm Josh
Camp4 Therapeutics | 3: Initial statement of beneficial ownership of securities-10% Owner Polaris Partners GP X, L.L.C.
Camp4 Therapeutics Corp. | 3: Initial statement of beneficial ownership of securities-10% Owner Polaris Management Co. VII, L.L.C.
Camp4 Therapeutics Corp. | 3: Initial statement of beneficial ownership of securities-10% Owner Enavate Sciences GP, LLC
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
